Deep learning for sensitive detection of Helicobacter Pylori in gastric biopsies

Helicobacter Pylori

Molecular diagnosis of Helicobacter pylori infection in gastric biopsies: Evaluation of the Amplidiag^® H. pylori + ClariR assay

doi: 10.1111/hel.12560.

Gastrointestinal CancerHelicobacter Pylori

Risk Factors and Incidence of Gastric Cancer After Detection of Helicobacter pylori Infection: A Large Cohort Study

Gastroenterology.

Kumar S, Metz DC, Ellenberg S, Kaplan DE, Goldberg DS

doi: 10.1053/j.gastro.2019.10.019.

Gastritis

Th-17 response and antimicrobial peptide expression are uniformly expressed in gastric mucosa of Helicobacter pylori-infected patients independently of their clinical outcomes

Helicobacter.

Cremniter J, Bodet C, Tougeron D, Dray X, Guilhot J, Jégou JF, Morel F, Lecron JC, Silvain C, Burucoa C

doi: 10.1111/hel.12479.

Helicobacter Pylori

Helicobacter pylori heteroresistance to clarithromycin in adults-New data by in situ detection and improved concept

Helicobacter.

Kocsmár É, Kocsmár I, Buzás GM, Szirtes I, Wacha J, Takáts A, Hritz I, Schaff Z, Rugge M, Fassan M, Kiss A, Lotz G

doi: 10.1111/hel.12670.

Helicobacter Pylori

Application of gene chip technology in the diagnostic and drug resistance detection of Helicobacter pylori in children

J Gastroenterol Hepatol.

Yin G, Bie S, Gu H, Shu X, Zheng W, Peng K, Zhao H, Li F, Chen B, Botchway BOA, Fang M, Jiang M

doi: 10.1111/jgh.14980.

Helicobacter Pylori

CRISPR-based detection of Helicobacter pylori in stool samples

Helicobacter

Qiu E, Jin S, Xiao Z, Chen Q, Wang Q, Liu H, Xie C, Chen C, Li Z, Han S

doi: 10.1111/hel.12828

Characterization of Helicobacter pylori-Naïve Early Gastric Cancers

Digestion.

Yamada A, Kaise M, Inoshita N, Toba T, Nomura K, Kuribayashi Y, Yamashita S, Furuhata T, Kikuchi D, Matsui A, Mitani T, Ogawa O, Iizuka T, Hoteya S

doi: 10.1159/000487795.

Helicobacter Pylori

Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost-effectiveness analysis

Helicobacter

Kowada A, Asaka M

doi: 10.1111/hel.12837

Gastrointestinal CancerHelicobacter Pylori

Long-term follow-up of serum pepsinogens in patients with gastric cancer or dysplasia after Helicobacter pylori eradication

J Gastroenterol Hepatol.

Noh G, Kim N, Choi Y, Lee HS, Hwang YJ, Kim HJ, Yoon H, Shin CM, Park YS, Lee DH

doi: 10.1111/jgh.15017.

Related content

Molecular diagnosis of Helicobacter pylori infection in gastric biopsies: Evaluation of the Amplidiag® H. pylori + ClariR assay

Risk Factors and Incidence of Gastric Cancer After Detection of Helicobacter pylori Infection: A Large Cohort Study

Th-17 response and antimicrobial peptide expression are uniformly expressed in gastric mucosa of Helicobacter pylori-infected patients independently of their clinical outcomes

Helicobacter pylori heteroresistance to clarithromycin in adults-New data by in situ detection and improved concept

Application of gene chip technology in the diagnostic and drug resistance detection of Helicobacter pylori in children

CRISPR-based detection of Helicobacter pylori in stool samples

Characterization of Helicobacter pylori-Naïve Early Gastric Cancers

Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost-effectiveness analysis

Long-term follow-up of serum pepsinogens in patients with gastric cancer or dysplasia after Helicobacter pylori eradication

Molecular diagnosis of Helicobacter pylori infection in gastric biopsies: Evaluation of the Amplidiag^® H. pylori + ClariR assay